Shenzhen Weiguang Biological Products Co Ltd 002880.SZ

Last Updated: May 15, 12:00 AM·SZSE

Shenzhen Weiguang Biological Products Co Ltd

Shenzhen Weiguang Biological Products Co Ltd. Stock Analysis 002880.SZ

China Health Care Small Cap
Shenzhen Weiguang Biological Products Co., Ltd. engages in the manufacturing, research and development of drug and blood products. The company is headquartered in Shenzhen, Guangdong and currently employs 901 full-time employees. The company went IPO on 2017-06-16. The firm's main products include human serum albumin, intravenous human immunoglobulin (pH4), rabies immunoglobulin, human fibrinogen, human coagulation factor VIII, and human prothrombin complex concentrate. The firm is also engaged in property leasing business. The firm conducts its businesses in domestic market.
Read More
Lock image
crown-icon

Shariah Compliance Report

An extensive business and financial screening of the company which specifies why a stock is halal or haram!

Disclaimer

The content provided on this website is intended solely for informational and educational purposes. Musaffa is a technology, data, education, and research company. We are not licensed financial service provider by the authorized relevant financial service regulator in India or any other regulatory government body, and we do not offer or facilitate any trading, brokerage, investment, or financial advisory services. We do not deliberately target an audience seeking financial services.

By accessing this website, you acknowledge and confirm that you are seeking information relating to Musaffa of your own accord, and that there has been no form of solicitation, advertisement, or inducement by Musaffa or its members. Musaffa shall not be liable for the consequences of any action taken by relying on the material or information provided on this website. The contents of this website are the intellectual property of Musaffa.